Pandect Bioventures collects $33m for $100m-targeted fund

Pandect Bioventures has raised $33 million for its new fund, according to an SEC filing. The target is $100 million. Based in South San Francisco, California, Pandect Bioventures targets early-stage biotech and pharma companies.

Source: SEC filing